Highlights include:

  • Interview with Dr. Alice Shaw regarding new ALK-inhibitor recently approved as a second line treatment.
  • The FDA’s new tobacco rule which extends its
    regulatory authority to all tobacco products, including small and large cigars, hookah tobacco, pipe tobacco, nicotine gels, dissolvable tobacco products, and electronic cigarettes (e-cigarettes).
  • Genetic differences in lung cancers arising in smokers and never-smokers
  • Chair of LCFA’s Scientific Advisory Board, Dr. David H. Johnson, recipient of the 2016 ASCO Distinguished Achievement Award, recognizing  leadership or mentorship by a scientist, practitioner, or researcher who has benefited patients with cancer or those who treat them.

Download the pdf newsletter: https://www.iaslc.org/sites/default/files/wysiwyg-assets/lungcancernews_v1n3_online.pdf